0

About Ebba Biotech

info@ebbabiotech.com

Ebba Biotech AB was founded in 2016 by professor Agneta Richter-Dahlfors to enable commercial applications and more widespread use of fluorescent tracer (optotracers) molecules, the result of many years of cutting-edge nanoscience and organic chemistry research. Ebba Biotech headoffice is based at Medeon (Science Park for Life Science in Malmö, Sweden) and professor Agneta Richter-Dahlfors has remains majority owner and chairman of the board. From the subsidiary located in Karolinska Institutet Science Park in Solna, Ebba Biotech produces, sells and delivers the many variants of purpose-built fluorescent tracer (optotracer) molecules to research laboratories, hospitals and industry worldwide.

“My passion has always been to make our nanoscience and organic chemistry research available to a wider audience. Finally, after spending years on research and development, we are ready and able to launch the full wavelength range of our fluorescent tracer (optotracer) molecule for probing and detecting bacterial biofilm under its new name EbbaBiolight. says founder and chairman of Ebba Biotech AB, Professor Agneta Richter-Dahlfors.

About our Technology

Optotracing is an innovative visualization method developed by scientists for scientists for use in fluorescence microscopy and spectroscopy. With optotracing – using fluorescent tracer molecules – Ebba Biotech provides an innovative method for several expanding areas of research. The optotracing technology has been developed by a scientific expert team of researchers at Karolinska Institutet, Linköping University and the Royal Institute of Technology (KTH) in Sweden and is a result of many years of cutting-edge nanoscience and organic chemistry research.

Ebba Biotech has commercialized distribution and sales of optotracer molecules and today supply these in three different series: